| Q39872176 | A human chromosome 12-associated 83-kilodalton cellular protein specifically binds to the loop region of human immunodeficiency virus type 1 trans-activation response element RNA. |
| Q36829057 | A minimal lentivirus Tat |
| Q33662926 | A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat |
| Q40396975 | Activation and inactivation of gene expression using RNA sequences |
| Q28247468 | Activation of transcription by HIV-1 Tat protein tethered to nascent RNA through another protein |
| Q40060891 | An adenosine at position 27 in the human immunodeficiency virus type 1 trans-activation response element is not critical for transcriptional or translational activation by Tat |
| Q41079020 | Analysis of Tat transactivation of human immunodeficiency virus transcription in vitro. |
| Q36828521 | Analysis of trans-acting response decoy RNA-mediated inhibition of human immunodeficiency virus type 1 transactivation |
| Q45860235 | Binding of Tat Protein to TAR Region of Human Immunodeficiency Virus Type 1 Blocks TAR-Mediated Activation of (2′-5′)Oligoadenylate Synthetase |
| Q40983909 | Broad-spectrum antiviral activity and mechanism of antiviral action of the fluoroquinolone derivative K-12. |
| Q28342742 | Cell type-specific anti-human immunodeficiency virus type 1 activity of the transactivation inhibitor Ro5-3335 |
| Q41576182 | Characterization of the inducer of short transcripts, a human immunodeficiency virus type 1 transcriptional element that activates the synthesis of short RNAs. |
| Q37251783 | Circular dichroism and molecular modeling yield a structure for the complex of human immunodeficiency virus type 1 trans-activation response RNA and the binding region of Tat, the trans-acting transcriptional activator |
| Q36697484 | Conserved nucleotides in the TAR RNA stem of human immunodeficiency virus type 1 are critical for Tat binding and trans activation: model for TAR RNA tertiary structure |
| Q36798014 | Critical chemical features in trans-acting-responsive RNA are required for interaction with human immunodeficiency virus type 1 Tat protein |
| Q41161690 | Cystatins in health and disease |
| Q35792991 | Detailed mutational analysis of TAR RNA: critical spacing between the bulge and loop recognition domains |
| Q36636851 | Direct interactions between autoantigen La and human immunodeficiency virus leader RNA. |
| Q35891706 | Down modulation of HIV-1 gene expression using a procaryotic RNA-binding protein |
| Q40041905 | Effects of human chromosome 12 on interactions between Tat and TAR of human immunodeficiency virus type 1. |
| Q36633736 | Effects of the Tat basic domain on human immunodeficiency virus type 1 transactivation, using chemically synthesized Tat protein and Tat peptides. |
| Q35835407 | Efficient trans-activation by the HIV-2 Tat protein requires a duplicated TAR RNA structure |
| Q36687332 | Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat |
| Q40228686 | Footprinting RNA-protein complexes following gel retardation assays: application to the R-17-procoat-RNA and tat--TAR interactions |
| Q24655684 | Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat |
| Q37056955 | Genetic regulation of human immunodeficiency virus. |
| Q41234955 | HIV-1 tat protein stimulates transcription by binding to a U-rich bulge in the stem of the TAR RNA structure |
| Q35928622 | Heterologous basic domain substitutions in the HIV-1 Tat protein reveal an arginine-rich motif required for transactivation |
| Q33575002 | Identification and characterization of a HeLa nuclear protein that specifically binds to the trans-activation-response (TAR) element of human immunodeficiency virus |
| Q40066797 | Identification of lentivirus tat functional domains through generation of equine infectious anemia virus/human immunodeficiency virus type 1 tat gene chimeras |
| Q24655901 | In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor |
| Q24568329 | Inhibition of HIV-1 Tat-mediated LTR transactivation and HIV-1 infection by anti-Tat single chain intrabodies |
| Q36638137 | Inhibition of human immunodeficiency virus type 1 in human T cells by a potent Rev response element decoy consisting of the 13-nucleotide minimal Rev-binding domain. |
| Q39880793 | Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists |
| Q40045425 | Juxtaposition between activation and basic domains of human immunodeficiency virus type 1 Tat is required for optimal interactions between Tat and TAR. |
| Q36700611 | Mutational analysis of the equine infectious anemia virus Tat-responsive element |
| Q40396291 | NMR analysis of the trans-activation response (TAR) RNA element of equine infectious anemia virus |
| Q24568366 | Novel mechanism and factor for regulation by HIV-1 Tat |
| Q39719048 | Optimal Tat-mediated activation of the HIV-1 LTR promoter requires a full-length TAR RNA hairpin |
| Q33719689 | RNA transcripts of the human immunodeficiency virus transactivation response element can inhibit action of the viral transactivator |
| Q40467663 | Regulation of HIV-1 Gene Expression by the Transactivator Protein Tat |
| Q24606166 | Relatedness of an RNA-binding motif in human immunodeficiency virus type 1 TAR RNA-binding protein TRBP to human P1/dsI kinase and Drosophila staufen |
| Q44916722 | Response to Comment on "Xist recruits the X chromosome to the nuclear lamina to enable chromosome-wide silencing". |
| Q33900660 | Sequence-specific interaction of Tat protein and Tat peptides with the transactivation-responsive sequence element of human immunodeficiency virus type 1 in vitro |
| Q28285441 | Sequential steps in Tat trans-activation of HIV-1 mediated through cellular DNA, RNA, and protein binding factors |
| Q36959657 | Site-specific cleavage of the transactivation response site of human immunodeficiency virus RNA with a tat-based chemical nuclease |
| Q42848859 | TAR RNA decoys inhibit tat-activated HIV-1 transcription after preinitiation complex formation |
| Q41238682 | TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes |
| Q40046655 | TAR loop-dependent human immunodeficiency virus trans activation requires factors encoded on human chromosome 12. |
| Q40062345 | TAR-independent replication of human immunodeficiency virus type 1 in glial cells |
| Q36639281 | TAR-independent transactivation of the murine cytomegalovirus major immediate-early promoter by the Tat protein |
| Q37059502 | Tat and Rev: positive modulators of human immunodeficiency virus gene expression |
| Q37594301 | Tat-dependent adenosine-to-inosine modification of wild-type transactivation response RNA. |
| Q36632734 | The human immunodeficiency virus type 1 Tat protein transactivates tumor necrosis factor beta gene expression through a TAR-like structure. |
| Q40597354 | The human immunodeficiency virus type-1 long terminal repeat and its role in gene expression |
| Q37548928 | The number of positively charged amino acids in the basic domain of Tat is critical for trans-activation and complex formation with TAR RNA |
| Q37506941 | The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation |
| Q24319734 | The type 1 human immunodeficiency virus Tat binding protein is a transcriptional activator belonging to an additional family of evolutionarily conserved genes |
| Q40526004 | Transactivation of heterologous promoters by HIV-1 tat. |
| Q39870080 | Transcriptional trans activation by human immunodeficiency virus type 1 Tat requires specific coactivators that are not basal factors. |
| Q38330641 | Unusual structure of the human immunodeficiency virus type 1 trans-activation response element |